Gene · 3598
Papers2,877
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 2,877
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| GD2 Expression in Medulloblastoma and Neuroblastoma for Personalized Immunotherapy: A Matter of Subtype. | Cancers (Basel) | 2022 | 36551537 | PubTator, text mining | PubMed |
| Dupilumab-Associated Mycosis Fungoides with a CD8+ Immunophenotype. | Dermatopathology (Basel) | 2022 | 36547219 | PubTator, text mining | PubMed |
| Clutch Control: Changing the Speed and Direction of CAR-T Cell Therapy. | J Cancer Immunol (Wilmington) | 2022 | 36531912 | PubTator, text mining | PubMed |
| Immune related biomarkers for cancer metastasis to the brain. | Exp Hematol Oncol | 2022 | 36527157 | PubTator, text mining | PubMed |
| A mAb against surface-expressed FSHR engineered to engage adaptive immunity for ovarian cancer immunotherapy. | JCI Insight | 2022 | 36509287 | PubTator, text mining | PubMed |
| Advances in CAR T cell immunotherapy for paediatric brain tumours. | Front Oncol | 2022 | 36505819 | PubTator, text mining | PubMed |
| Cancer immunotherapy with CAR T cells: well-trodden paths and journey along lesser-known routes. | Radiol Oncol | 2022 | 36503716 | PubTator, text mining | PubMed |
| Key Genetic Components of Fibrosis in Diabetic Nephropathy: An Updated Systematic Review and Meta-Analysis. | Int J Mol Sci | 2022 | 36499658 | PubTator, text mining | PubMed |
| Pulmonary Fibrosis as a Result of Acute Lung Inflammation: Molecular Mechanisms, Relevant In Vivo Models, Prognostic and Therapeutic Approaches. | Int J Mol Sci | 2022 | 36499287 | PubTator, text mining | PubMed |
| Efficacy, Safety, and Challenges of CAR T-Cells in the Treatment of Solid Tumors. | Cancers (Basel) | 2022 | 36497465 | PubTator, text mining | PubMed |
Immune and non-immune cell subtypes identify novel targets for prognostic and therapeutic strategy: A study based on intratumoral heterogenicity analysis of multicenter scRNA-seq datasets in lung adenocarcinoma. | Front Immunol | 2022 | 36483553 | PubTator, text mining | PubMed |
| Pediatric versus adult high grade glioma: Immunotherapeutic and genomic considerations. | Front Immunol | 2022 | 36483545 | PubTator, text mining | PubMed |
| Severe pediatric asthma therapy: Dupilumab. | Front Pediatr | 2022 | 36483465 | PubTator, text mining | PubMed |
| The immunosuppressive microenvironment and immunotherapy in human glioblastoma. | Front Immunol | 2022 | 36466873 | PubTator, text mining | PubMed |
| The IAP antagonist birinapant enhances chimeric antigen receptor T cell therapy for glioblastoma by overcoming antigen heterogeneity. | Mol Ther Oncolytics | 2022 | 36458202 | PubTator, text mining | PubMed |
| Crucial role of T cells in NAFLD-related disease: A review and prospect. | Front Endocrinol (Lausanne) | 2022 | 36457551 | PubTator, text mining | PubMed |
| Cutting edges and therapeutic opportunities on tumor-associated macrophages in lung cancer. | Front Immunol | 2022 | 36439090 | PubTator, text mining | PubMed |
| Mass cytometry reveals cladribine-induced resets among innate lymphoid cells in multiple sclerosis. | Sci Rep | 2022 | 36437270 | PubTator, text mining | PubMed |
| Plasma IL13Rα2 as a novel liquid biopsy biomarker for glioblastoma. | J Neurooncol | 2022 | 36436150 | PubTator, text mining | PubMed |
| Mechanisms of colorectal liver metastasis development. | Cell Mol Life Sci | 2022 | 36436127 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3598/papers?page=30